Leadership & Expert Views - Cancer Currents Blog
Commentaries from scientific leaders at NCI and other institutions about cancer research topics, programs, and initiatives.
-
To mark the 10 years since it was named a national lab, NCI Principal Deputy Director Douglas R. Lowy, M.D., discusses some of the Frederick National Lab’s initiatives to support cancer research and looks ahead at the next 10 years.
-
NCI Director Dr. Monica Bertagnolli reflects on the tremendous progress made in cancer research over the past 3 decades, important opportunities that lie ahead, and the need for coordinated, all-of-society collaboration to end cancer as we know it for everyone.
-
To mark her first year at NCI, Dr. Katrina Goddard lays out her research priorities for the Division of Cancer Control and Population Sciences and outlines key opportunities for reducing the burden of cancer. These future directions and priorities are outlined in the division’s 2022 Overview and Highlights report.
-
The number of participants in modern phase 1 cancer clinical trials whose cancer responded to the treatment or remained stable has increased substantially, while treatment-related deaths remained very low, a new NCI study shows. Dr. Naoko Takebe discusses the findings and the importance of phase 1 trials.
-
Dr. Doug Hawkins, chair of the NCI-funded Children’s Oncology Group, discusses advances in treating children with cancer, COG’s role in conducting clinical trials, and efforts like the Childhood Cancer Data Initiative and Molecular Characterization Initiative.
-
About 25% of cancer survivors have persistent anxiety, depression, or other psychological and social (psychosocial) distress. In this interview, Dr. Patricia Ganz discusses psychosocial distress and the challenges and opportunities in this area.
-
Progress has been made on developing noninvasive tests that may be able to find many cancers early. But, as NCI’s Dr. Phil Castle explains, there’s still much to learn about these multi-cancer early detection tests before they become widely used.
-
With the passage of the Air is Life Act of 2021, the Navajo Nation enacted the most comprehensive ban on commercial tobacco products of any American Indian tribe to date.
-
Dr. John P. Williams, chair of the President’s Cancer Panel, summarizes the panel’s new report, Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access.
-
Companies that want to market e-cigarettes in the United States must now submit applications to the Food and Drug Administration (FDA). In this interview, Mitch Zeller, director of FDA’s Center for Tobacco Products, provides insights into FDA actions on e-cigarettes.